In addition, GPS2 expression is reduced in a variety of tumors (such as osteosarcoma and melanoma) and adipose tissues, indicating that GPS2 is closely related to tumor cell proliferation and lipid-associated inflammation [26, 27]. The gene discussed is GPS2; the disease is melanoma.